CYP3A4 and obesity due to melanocortin 4 receptor deficiency: For example, a pediatric study of the CYP3A4 substrate midazolam reported a 38% increase in absolute clearance with obesity, possibly conflicting with adult reports due to lower comorbidity rates in pediatric obesity (van Rongen et al., 2018).